Windtree Therapeutics Inc (WINT) poses a Brand-New Opportunity for Investors with beta value of 0.61
Windtree Therapeutics Inc (NASDAQ: WINT) established initial surge of 4.26% at $0.12, before settling in for the price of $0.12 at the close. Taking a